A meta-analysis of the predictive value of different images for benign and malignant ovarian tumors

Meihua Wu,Zhengyi Chen,Jianfa Lan,Qionghua Chen

DOI: https://doi.org/10.1016/j.wfumbo.2024.100059

2024-01-01

WFUMB Ultrasound Open

Abstract:Objective To compare the discriminative value of ultrasound (US), computed tomography (CT) and magnetic resonance imaging (MRI) for benign and ovarian tumors. Methods Between January 2000 and August 2023, English publications in PubMed and Embase on the diagnosis of benign and malignant ovarian or adnexal tumors diagnosed by ultrasound, CT, or MRI were included. Studies were chosen if they had data that could be utilized to build a two-by-two league table comparing ultrasonography, CT, and MRI. A random-effects model was used to calculate the sensitivity and specificity of ultrasonography, CT, and MRI, and meta-regression was used to examine study heterogeneity. Results This meta-analysis comprised 47 articles, including 13 ultrasound,8 CT, and 30 MRI investigations on the identification of benign and malignant tumors in ovary or adnexa (including four CT and MRI co-studies). The combined sensitivity and specificity of ultrasonography for diagnosing were 0.92 (95% CI: 0.91-0.93) and 0.93 (95% CI: 0.92-0.93), respectively, while CT was 0.86 (95% CI: 0.82-0.89) and 0.76 (95% CI: 0.71-0.81). MRI had a combined sensitivity and specificity of 0.90 (95% CI:0.88-0.91) and 0.89 (95% CI:0.88-0.90). Conclusion Both ultrasound and MRI demonstrated excellent and comparable diagnostic efficacy in the differential diagnosis of benign and malignant ovarian or adnexal lesions, and both were superior to CT. Since ultrasound may be the main choice for general adnexal mass screening.